Related Experiment Video
Updated: Apr 26, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Subdural hemorrhages associated with antithrombotic therapy in infants with cerebral atrophy
Louis T Dang1, Jordan A Shavit2, Rani K Singh3
1Divisions of Pediatric Neurology, louisdan@med.umich.edu.
Insights
Enoxaparin, a low-molecular-weight heparin, can treat infant thrombosis but may increase intracranial hemorrhage risk in infants with diffuse brain injury. Careful consideration is needed before prescribing enoxaparin to this vulnerable population.
Area of Science:
- Pediatric Neurology
- Neonatal Thrombosis
- Neurocritical Care
Background:
- Low-molecular-weight heparins like enoxaparin are standard treatments for thrombosis in infants.
- Diffuse brain injury is a serious condition in neonates and infants.
Observation:
- Four infants with diffuse brain injury developed cerebral venous sinus thrombosis or deep vein thrombosis.
- These infants were treated with enoxaparin, a common anticoagulant.
- Subdural hemorrhages were observed in all four infants following enoxaparin treatment.
Findings:
- Enoxaparin treatment was discontinued after the development of subdural hemorrhages.
- Two infants required urgent neurosurgical intervention for their hemorrhages.
- Subdural hemorrhages showed improvement or resolution on follow-up neuroimaging.
- Severe neurological deficits were noted in all infants, likely attributed to the underlying diffuse brain injury.
Implications:
- The risk of intracranial hemorrhage from enoxaparin may be heightened in infants with diffuse brain injury.
- Clinicians should exercise caution when considering enoxaparin for thrombosis treatment in infants with diffuse brain injury.
- Further research is warranted to elucidate the specific risks and benefits in this patient group.
Abstract:
Low-molecular-weight heparins, such as enoxaparin, are often used to treat thrombosis in infants. We present 4 infants with diffuse brain injury who developed cerebral venous sinus thrombosis or deep vein thrombosis and were treated with enoxaparin. These infants subsequently developed subdural hemorrhages, and enoxaparin was stopped. In 3 cases, the subdural hemorrhages were found on routine surveillance brain MRI, and in 1 case imaging was urgently obtained because of focal seizures. Two patients needed urgent neurosurgical intervention, and all subdural hemorrhages improved or resolved on follow-up imaging. Each infant developed severe neurologic deficits, probably from the coexisting diffuse brain injury rather than from the subdural hemorrhages themselves. The risk of intracranial hemorrhage from enoxaparin may be accentuated in patients with diffuse brain injury, and careful consideration should be given before treatment in this population.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Increased Intracranial Pressure ll: Pathophysiology

